Biotek-snakken — December 2021
-
Lilly sender amerikanske biotekaktie til vejrs med stor aftale https://www.proinvestor.com/investornyt/748494/lilly-sender-amerikanske-biotekaktie-til-vejrs-med-stor-aftale
-
Xbrane initierar utveckling av två nya biosimilarkandidater och bygger en biosimilarportfölj inom onkologi som adresserar €23 miljarder i årlig försäljning på referensprodukterna
-
Roche's SARS-CoV-2 Antigen Self Test Nasal Gets Approval In Canada
https://www.proinvestor.com/investornyt/748998/roches-sars-cov-2-antigen-self-test-nasal-gets-approval-in-canada -
GN Hearing acquires New York based Lively https://www.proinvestor.com/index.php?p=debat_1&postid=99425
-
Merck's HIV Trials Put On Clinical Hold, Vifor Gets A Suitor, VERU Scores FDA Nod...https://www.proinvestor.com/investornyt/749005/mercks-hiv-trials-put-on-clinical-hold-vifor-gets-a-suitor-veru-scores-fda-nod
-
Australia's CSL Agrees To Buy Vifor Pharma For $11.7 Bln In Cash - Quick Facts
https://www.proinvestor.com/investornyt/749001/australias-csl-agrees-to-buy-vifor-pharma-for-117-bln-in-cash-quick-facts -
Molecular Announces License Deal With
Novartis For At Least Up To $580 Mln https://www.proinvestor.com/investornyt/749004/molecular-announces-license-deal-with-novartis-for-at-least-up-to-580-mln -
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind